Aurobindo Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Aurobindo Pharma Ltd. on BSE

Load latest

Aurobindo Pharma Ltd.

08 Aug 2025

1119.20

-0.86%

Earnings Call

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Submission of transcript of earnings call on the Unaudited Financial Results for the first quarter ended June 30. 2025.

pdf

Aurobindo Pharma Ltd.

06 Aug 2025

1119.20

-0.86%

Company Update

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of newspaper advertisement of Unaudited Financial Results of the Company for the first quarter ended June 30, 2025 as published in Business Standard and Nava Telangana on August 6, 2025.

pdf

Aurobindo Pharma Ltd.

04 Aug 2025

1119.20

-0.86%

Company Update

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Submission of Press release on unaudited Financial Results for the first quarter ended June 30, 2025

pdf

Aurobindo Pharma Ltd.

04 Aug 2025

1119.20

-0.86%

Investor Presentation

Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Submission of Investor Presentation that would be used in the investors/analyst call on unaudited financial results of the Company for the first quarter ended June 30,2025

pdf

Aurobindo Pharma Ltd.

04 Aug 2025

1119.20

-0.86%

Corp. Action

Aurobindo Pharma Ltd - 524804 - Intimation Of Record Date For Payment Of Interim Dividend For …

BSE India

Intimation of Record Date for payment of Interim Dividend for the FY 2025-26

pdf

Aurobindo Pharma Ltd.

04 Aug 2025

1119.20

-0.86%

Corp. Action

Aurobindo Pharma Ltd - 524804 - Corporate Action-Board approves Dividend

BSE India

The Board of Directors of the company at its meeting held today August 4, 2025, has approved the payment of Interim Dividend of 400% i.e Rs.4.00 (Rupees Four Only) per equity share of Rs.1. /- each on equity share capital of the company, The Company has fixed August 8, 2025 as the record date for purpose of the payment of interim Dividend and the same will paid on or before August 21, 2025.

pdf

Aurobindo Pharma Ltd.

04 Aug 2025

1119.20

-0.86%

Board Meeting

Aurobindo Pharma Ltd - 524804 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

The Board of Directors of the Company at its meeting held today, August 4, 2025, has, inter alia, considered and approved: - 1. the standalone and consolidated Unaudited Financial Results of the Company for the first quarter ended June 30, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Unaudited Financial Results of the Company along with the Limited Review Reports issued by the Statutory Auditors. 2. the payment of interim dividend of 400% i.e. Rs.4.00 (Rupee Four only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has fixed August 8, 2025, as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before August 21, 2025.

pdf

Aurobindo Pharma Ltd.

01 Aug 2025

1119.20

-0.86%

Company Update

Aurobindo Pharma Ltd - 524804 - Clarification On News Item Appearing In 'Media/Publication

BSE India

Submission of clarification on news items appearing in Media.

pdf

Aurobindo Pharma Ltd.

01 Aug 2025

1119.20

-0.86%

Company Update

Aurobindo Pharma Ltd - 524804 - Clarification sought from Aurobindo Pharma Ltd

BSE India

The Exchange has sought clarification from Aurobindo Pharma Ltd on August 1, 2025, with reference to news appeared in https://www.moneycontrol.com dated August 1, 2025 quoting "Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices".The reply is awaited.